Japan Medical
Tokyo, Japan International Patient Support
Contact Us

DIABETES TREATMENT

Diabetes Treatment

Stem-cell therapy activates innate repair and addresses metabolic imbalance at its root.

  • Glucose Stability
  • Islet Support
  • Fewer Complications
SCROLL

Root-Level Approach

Stem-Cell Therapy Addresses Diabetes at Its Root

Treatment aims to support pancreatic islet function, improve the inflammatory microenvironment, enhance insulin sensitivity and protect vessels and nerves from progressive diabetic damage.

Four Core Mechanisms

A deeper, more considered approach

  • Support pancreatic islet β-cell function and natural insulin secretion.
  • Modulate immune responses and reduce chronic inflammation.
  • Improve hepatic and muscular insulin sensitivity.
  • Support vascular repair and neuroprotection to delay complications.

Metabolic Care Standard

Not All Stem-Cell Therapies Can Truly Improve Diabetes

01

Research-Grade Capability

One of Japan’s largest stem-cell research and culture centers, with a self-operated large CPC and an in-clinic real-time CPC.
02

Younger, Purer Cells

Low-passage culture within three generations, serum-free media and meticulous 1:1 manual cultivation preserve reparative potential.
03

Freshness Without Freezing

Immediate in-clinic handling and secondary washing protect viability, prevent aggregation and support efficient reinfusion.
04

High Cell Quantity

A single infusion can deliver 250–300 million high-viability stem cells, far above common market levels.
05

Systemic Repair Strategy

Treatment planning combines cellular rejuvenation, microenvironment improvement and functional repair support.
06

Strict Safety Standards

Cell handling is performed in a Class-100 sterile environment using additive-free, antibiotic-free processes.

Clinical Goals

Main Clinical Improvements

  • Support islet β-cells and endogenous islet function
  • Stabilize fasting and postprandial glucose
  • Reduce chronic diabetic inflammation
  • Improve microcirculation and tissue oxygenation
  • Relieve fatigue and improve quality of life

Suitable Candidates

Designed for individual needs

  • People with type 1 or type 2 diabetes
  • Large glucose fluctuations despite medication
  • High risk of complications seeking to slow progression
  • Long-standing diabetes with poor recovery or declining stamina

Case Sharing

Observed changes and clinical stories

Case 1 — Insulin Reduction

After an infusion of 200 million cells, HbA1c fell to 5.4% and glucose to 90. Insulin was gradually reduced to once every three days.

Case 2 — HbA1c Improvement

A patient in their 70s saw HbA1c improve from 10.5 to 7.1 after the first infusion.

Private, professional, precise

Safety, Serenity, Reassurance — Your Triple Assurance

GINZA CLINIC is equipped with a Japanese medical-grade CPC laboratory. Consultation, collection, culture and reinfusion follow independent, standardized and stringent aseptic processes. One-to-one physician-led care protects privacy, peace of mind and efficiency.